<Summary id="CDR0000442381" LegacyPDQID="" ReplacementFor="CDR0000062710"><SummaryMetaData><SummaryType>Treatment</SummaryType><SummaryAudience>Patients</SummaryAudience><SummaryLanguage>English</SummaryLanguage><SummaryDescription>Kaposi sarcoma treatment depends upon the type and can include scraping to remove a lesion, radiation therapy, surgery, and sometimes chemotherapy.  Learn more about the diagnosis and treatment of newly diagnosed and recurrent Kaposi sarcoma in this expert-reviewed summary.</SummaryDescription><SummaryURL xref="https://www.cancer.gov/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq">Kaposi Sarcoma (PDQ®): Treatment</SummaryURL><SummaryToggleURL xref="https://www.cancer.gov/types/soft-tissue-sarcoma/hp/kaposi-treatment-pdq">Kaposi Sarcoma (PDQ®): Treatment</SummaryToggleURL><SummaryEditorialBoard ref="CDR0000028327">PDQ Adult Treatment Editorial Board</SummaryEditorialBoard><MainTopics><TermRef ref="CDR0000038811">Kaposi sarcoma</TermRef></MainTopics><SummaryAbstract><Para id="_222">This PDQ cancer information summary has current information about the treatment of Kaposi sarcoma. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para><Para id="_223">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Date Last Modified") is the date of the most recent change. The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the PDQ Adult Treatment Editorial Board.</Para></SummaryAbstract><SummaryKeyWords><SummaryKeyWord>Kaposi sarcoma</SummaryKeyWord></SummaryKeyWords></SummaryMetaData><SummaryTitle>Kaposi Sarcoma Treatment (PDQ®)–Patient Version</SummaryTitle><AltTitle TitleType="Browser">Kaposi Sarcoma Treatment</AltTitle><AltTitle TitleType="CancerTypeHomePage">Kaposi Sarcoma Treatment</AltTitle><SummarySection id="_1"><Title>General Information About Kaposi Sarcoma</Title><SummarySection id="_2"><SectMetaData><SectionType>Cancer description</SectionType><SectionType>Organ description</SectionType></SectMetaData><KeyPoint id="_3">Kaposi sarcoma is a disease in which malignant lesions (cancer) can form in  the skin, mucous membranes, lymph nodes, and other organs.</KeyPoint><Para id="_4"> <GlossaryTermRef href="CDR0000045134" dictionary="Cancer.gov" audience="Patient">Kaposi sarcoma</GlossaryTermRef> is a <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef> that causes <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef> (<GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissue</GlossaryTermRef>) to grow in the skin; the <GlossaryTermRef href="CDR0000257212" dictionary="Cancer.gov" audience="Patient">mucous membranes</GlossaryTermRef>  lining the mouth, nose, and <GlossaryTermRef href="CDR0000439429" dictionary="Cancer.gov" audience="Patient">throat</GlossaryTermRef>; <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef>; or other <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organs</GlossaryTermRef>. The lesions are usually purple and are made of cancer <GlossaryTermRef href="CDR0000046476" dictionary="Cancer.gov" audience="Patient">cells</GlossaryTermRef>, new <GlossaryTermRef href="CDR0000045020" dictionary="Cancer.gov" audience="Patient">blood vessels</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046124" dictionary="Cancer.gov" audience="Patient">red blood cells</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000045993" dictionary="Cancer.gov" audience="Patient">white blood cells</GlossaryTermRef>. Kaposi sarcoma is different from other cancers in that lesions may begin in more than one place in the body at the same time.</Para><Para id="_171">   <GlossaryTermRef href="CDR0000430695" dictionary="Cancer.gov" audience="Patient">Human herpesvirus-8</GlossaryTermRef> (HHV-8) is found in the lesions of all patients with Kaposi sarcoma. This <GlossaryTermRef href="CDR0000045941" dictionary="Cancer.gov" audience="Patient">virus</GlossaryTermRef> is also called Kaposi sarcoma herpesvirus (KSHV). Most people with HHV-8 do not get Kaposi sarcoma. People with HHV-8 are more likely to develop Kaposi sarcoma if their <GlossaryTermRef href="CDR0000046356" dictionary="Cancer.gov" audience="Patient">immune system</GlossaryTermRef> is weakened by disease, such as <GlossaryTermRef href="CDR0000044366" dictionary="Cancer.gov" audience="Patient">human immunodeficiency virus</GlossaryTermRef> (HIV), or by <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drugs</GlossaryTermRef> given after an organ <GlossaryTermRef href="CDR0000046631" dictionary="Cancer.gov" audience="Patient">transplant</GlossaryTermRef>.</Para><Para id="_235">There are several types of Kaposi sarcoma. The two types discussed in this summary include:</Para><ItemizedList id="_123" Style="bullet"><ListItem><SummaryRef href="CDR0000442381#_125" url="/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq">Classic Kaposi sarcoma</SummaryRef>.</ListItem><ListItem><SummaryRef href="CDR0000442381#_131" url="/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq">Epidemic Kaposi sarcoma (HIV-associated Kaposi sarcoma)</SummaryRef>.</ListItem></ItemizedList></SummarySection><SummarySection id="_16"><SectMetaData><SectionType>Diagnostic tests</SectionType></SectMetaData><KeyPoint id="_17">Tests that examine the skin, lungs, and gastrointestinal tract are used to diagnose Kaposi sarcoma.</KeyPoint><Para id="_18">In addition to asking about your <GlossaryTermRef href="CDR0000642019" dictionary="Cancer.gov" audience="Patient">personal</GlossaryTermRef> and <GlossaryTermRef href="CDR0000642015" dictionary="Cancer.gov" audience="Patient">family health history</GlossaryTermRef> and doing a <GlossaryTermRef href="CDR0000270871" dictionary="Cancer.gov" audience="Patient">physical exam</GlossaryTermRef>, your doctor may perform the following tests and procedures:</Para><ItemizedList id="_19" Style="bullet">
    <ListItem><Strong><GlossaryTermRef href="CDR0000304687" dictionary="Cancer.gov" audience="Patient">Chest x-ray</GlossaryTermRef></Strong>: An <GlossaryTermRef href="CDR0000045944" dictionary="Cancer.gov" audience="Patient">x-ray</GlossaryTermRef> of the organs and bones inside the chest. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body. This is used to find Kaposi sarcoma in the <GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">lungs</GlossaryTermRef>.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045164" dictionary="Cancer.gov" audience="Patient">Biopsy</GlossaryTermRef></Strong>: The removal of cells or tissues so they can be viewed under a <GlossaryTermRef href="CDR0000638184" dictionary="Cancer.gov" audience="Patient">microscope</GlossaryTermRef> by a <GlossaryTermRef href="CDR0000046244" dictionary="Cancer.gov" audience="Patient">pathologist</GlossaryTermRef> to check for signs of cancer. <Para id="_213">One of the following types of
			 biopsies may be done to check for Kaposi sarcoma lesions in the skin:</Para><ItemizedList id="_214" Style="bullet"><ListItem><Strong><GlossaryTermRef href="CDR0000046411" dictionary="Cancer.gov" audience="Patient">Excisional
				  biopsy</GlossaryTermRef></Strong>: A <GlossaryTermRef href="CDR0000257527" dictionary="Cancer.gov" audience="Patient">scalpel</GlossaryTermRef> is used to remove the entire skin growth. </ListItem> 
				<ListItem><Strong><GlossaryTermRef href="CDR0000046698" dictionary="Cancer.gov" audience="Patient">Incisional
				  biopsy</GlossaryTermRef></Strong>: A scalpel is used to remove part of a skin growth.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045657" dictionary="Cancer.gov" audience="Patient">Core
				  biopsy</GlossaryTermRef></Strong>: A wide needle is used to remove part of a skin growth.</ListItem> 
				<ListItem><Strong><GlossaryTermRef href="CDR0000045691" dictionary="Cancer.gov" audience="Patient">Fine-needle aspiration (FNA) biopsy</GlossaryTermRef></Strong>: A thin needle is used to remove part of a skin growth.</ListItem></ItemizedList><Para id="_215">An <GlossaryTermRef href="CDR0000045678" dictionary="Cancer.gov" audience="Patient">endoscopy</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045628" dictionary="Cancer.gov" audience="Patient">bronchoscopy</GlossaryTermRef> may be done to check for Kaposi sarcoma lesions in the <GlossaryTermRef href="CDR0000046189" dictionary="Cancer.gov" audience="Patient">gastrointestinal tract</GlossaryTermRef> or lungs.</Para><ItemizedList id="_216" Style="bullet"><ListItem><Strong>Endoscopy for biopsy</Strong>: A procedure to look at organs and tissues inside the body to check for abnormal areas. An <GlossaryTermRef href="CDR0000046428" dictionary="Cancer.gov" audience="Patient">endoscope</GlossaryTermRef> is inserted through an <GlossaryTermRef href="CDR0000046353" dictionary="Cancer.gov" audience="Patient">incision</GlossaryTermRef> (cut) in the skin or opening in the body, such as the mouth. An endoscope is a thin, tube-like instrument with a light and a <GlossaryTermRef href="CDR0000572035" dictionary="Cancer.gov" audience="Patient">lens</GlossaryTermRef> for viewing. It may also have a tool to remove tissue or lymph node samples, which are checked under a microscope for signs of disease. This is used to find Kaposi sarcoma lesions in the gastrointestinal tract.</ListItem>
    <ListItem><Strong>Bronchoscopy for biopsy</Strong>: A procedure to look inside the <GlossaryTermRef href="CDR0000046623" dictionary="Cancer.gov" audience="Patient">trachea</GlossaryTermRef> and large airways in the lung for abnormal areas. A <GlossaryTermRef href="CDR0000046496" dictionary="Cancer.gov" audience="Patient">bronchoscope</GlossaryTermRef>  is inserted through the nose or mouth into the trachea and lungs. A bronchoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue samples, which are checked under a microscope for signs of   disease. This is used to find Kaposi sarcoma lesions in the lungs.</ListItem></ItemizedList></ListItem>
    
    
   </ItemizedList></SummarySection><SummarySection id="_217"><KeyPoint id="_218">After Kaposi sarcoma has been diagnosed, tests are done to find out if cancer cells have spread to other parts of the body.</KeyPoint><Para id="_219">The following tests and procedures may be used to find out if cancer has spread to other parts of the body:</Para><ItemizedList id="_220" Style="bullet"><ListItem><Strong><GlossaryTermRef href="CDR0000304685" dictionary="Cancer.gov" audience="Patient">Blood chemistry studies</GlossaryTermRef></Strong>: A procedure in which a <GlossaryTermRef href="CDR0000270735" dictionary="Cancer.gov" audience="Patient">blood</GlossaryTermRef> sample is checked to measure the amounts of certain substances released into the blood by organs and tissues in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046033" dictionary="Cancer.gov" audience="Patient">CT scan</GlossaryTermRef> (CAT scan)</Strong>: A procedure that makes a series of detailed pictures of areas inside the body, such as the lung, <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000046593" dictionary="Cancer.gov" audience="Patient">spleen</GlossaryTermRef>, taken from different angles.  The pictures are made by a computer linked to an x-ray machine. A dye may be <GlossaryTermRef href="CDR0000044678" dictionary="Cancer.gov" audience="Patient">injected</GlossaryTermRef> into a <GlossaryTermRef href="CDR0000476471" dictionary="Cancer.gov" audience="Patient">vein</GlossaryTermRef> or swallowed to help the organs or tissues show up more clearly.  This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046140" dictionary="Cancer.gov" audience="Patient">PET scan</GlossaryTermRef> (positron emission tomography scan)</Strong>: A procedure to find <GlossaryTermRef href="CDR0000045772" dictionary="Cancer.gov" audience="Patient">malignant</GlossaryTermRef> lesions in the body.  A small amount of <GlossaryTermRef href="CDR0000046550" dictionary="Cancer.gov" audience="Patient">radioactive</GlossaryTermRef> <GlossaryTermRef href="CDR0000044033" dictionary="Cancer.gov" audience="Patient">glucose</GlossaryTermRef> (sugar) is injected into a vein.  The PET <GlossaryTermRef href="CDR0000386220" dictionary="Cancer.gov" audience="Patient">scanner</GlossaryTermRef> rotates around the body and makes a picture of where glucose is being used in the body.  Malignant lesions show up brighter in the picture because they are more active and take up more glucose than normal cells do. This <GlossaryTermRef href="CDR0000689578" dictionary="Cancer.gov" audience="Patient">imaging test</GlossaryTermRef> checks for signs of cancer in the lung, liver, and spleen.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045638" dictionary="Cancer.gov" audience="Patient">CD34</GlossaryTermRef> <GlossaryTermRef href="CDR0000045765" dictionary="Cancer.gov" audience="Patient">lymphocyte</GlossaryTermRef> count</Strong>: A procedure in which a blood sample is checked to measure the amount of CD34 cells (a type of white blood cell). A lower than normal amount of CD34 cells can be a sign the immune system is not working well.</ListItem></ItemizedList></SummarySection><SummarySection id="_20"><SectMetaData><SectionType>Prognostic factors</SectionType></SectMetaData><KeyPoint id="_21">Certain factors affect prognosis (chance of recovery) and treatment options.</KeyPoint><Para id="_22">The <GlossaryTermRef href="CDR0000045849" dictionary="Cancer.gov" audience="Patient">prognosis</GlossaryTermRef> and treatment options depend on the following: </Para><ItemizedList id="_23" Style="bullet">
    <ListItem>The type of Kaposi sarcoma.</ListItem>
    <ListItem>The general health of the patient, especially  the patient's immune system.</ListItem><ListItem>Whether the cancer has just been <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnosed</GlossaryTermRef> or has <GlossaryTermRef href="CDR0000046556" dictionary="Cancer.gov" audience="Patient">recurred</GlossaryTermRef> (come back).</ListItem>
    
   </ItemizedList></SummarySection></SummarySection><SummarySection id="_125"><SectMetaData><SectionType>Cancer description</SectionType></SectMetaData><Title>Classic Kaposi Sarcoma</Title><SummarySection id="_158"><KeyPoint id="_126">Classic Kaposi sarcoma is  found most often in older men of Italian or Eastern European Jewish origin.</KeyPoint><Para id="_127">Classic <GlossaryTermRef href="CDR0000045134" dictionary="Cancer.gov" audience="Patient">Kaposi sarcoma</GlossaryTermRef> is a rare disease  that gets worse slowly over many years.   </Para></SummarySection><SummarySection id="_159"><KeyPoint id="_160">Signs of classic Kaposi sarcoma may include slow-growing lesions on the legs and feet.</KeyPoint><Para id="_128">Patients may have one or more red, purple, or brown skin <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef>  on the legs and feet,  most often on the ankles or soles of the feet. Over time, lesions may form in other parts of the body, such as the <GlossaryTermRef href="CDR0000046604" dictionary="Cancer.gov" audience="Patient">stomach</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046335" dictionary="Cancer.gov" audience="Patient">intestines</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef>. The  lesions usually don't cause any <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef> but may grow in size and number over a period of 10  years or more.  Pressure from the lesions may block the flow of <GlossaryTermRef href="CDR0000046305" dictionary="Cancer.gov" audience="Patient">lymph</GlossaryTermRef> and <GlossaryTermRef href="CDR0000270735" dictionary="Cancer.gov" audience="Patient">blood</GlossaryTermRef> in the legs and cause  painful swelling. Lesions in the <GlossaryTermRef href="CDR0000046447" dictionary="Cancer.gov" audience="Patient">digestive tract</GlossaryTermRef> may cause <GlossaryTermRef href="CDR0000045692" dictionary="Cancer.gov" audience="Patient">gastrointestinal</GlossaryTermRef> bleeding.</Para></SummarySection><SummarySection id="_161"><KeyPoint id="_162">Another cancer may develop.</KeyPoint><Para id="_157"> Some patients with classic Kaposi sarcoma may develop another type of <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef> before the Kaposi sarcoma lesions appear or later in life. Most often, this <GlossaryTermRef href="CDR0000046658" dictionary="Cancer.gov" audience="Patient">second cancer</GlossaryTermRef> is  <GlossaryTermRef href="CDR0000045148" dictionary="Cancer.gov" audience="Patient">non-Hodgkin lymphoma</GlossaryTermRef>. Frequent <GlossaryTermRef href="CDR0000044671" dictionary="Cancer.gov" audience="Patient">follow-up</GlossaryTermRef> is needed to watch for these second cancers.</Para></SummarySection></SummarySection><SummarySection id="_131"><SectMetaData><SectionType>Cancer description</SectionType></SectMetaData><Title>Epidemic Kaposi Sarcoma (HIV-Associated Kaposi Sarcoma)</Title><SummarySection id="_153"><KeyPoint id="_132">Patients with HIV are at risk of developing epidemic Kaposi sarcoma (HIV-associated Kaposi sarcoma).</KeyPoint><Para id="_236"><GlossaryTermRef href="CDR0000044365" dictionary="Cancer.gov" audience="Patient">AIDS</GlossaryTermRef> is caused by <GlossaryTermRef href="CDR0000044985" dictionary="Cancer.gov" audience="Patient">HIV</GlossaryTermRef>, which attacks and weakens the body's <GlossaryTermRef href="CDR0000046356" dictionary="Cancer.gov" audience="Patient">immune system</GlossaryTermRef>. A weakened immune system is unable to fight <GlossaryTermRef href="CDR0000045364" dictionary="Cancer.gov" audience="Patient">infection</GlossaryTermRef> and disease. People with HIV have an increased risk of infection and <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef>.</Para><Para id="_237">A person with HIV and certain types of infection or cancer, such as <GlossaryTermRef href="CDR0000045134" dictionary="Cancer.gov" audience="Patient">Kaposi sarcoma</GlossaryTermRef>, is <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnosed</GlossaryTermRef> as having AIDS. Sometimes, a person is  diagnosed with AIDS and epidemic Kaposi sarcoma at the same time.</Para></SummarySection><SummarySection id="_166"><KeyPoint id="_167">The use of drug therapy  called highly active antiretroviral therapy (HAART)       reduces the risk of epidemic Kaposi  sarcoma in patients with HIV.</KeyPoint><Para id="_238"><GlossaryTermRef href="CDR0000306504" dictionary="Cancer.gov" audience="Patient">HAART</GlossaryTermRef> is a combination of several <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drugs</GlossaryTermRef> used to lessen the damage to the immune system caused by HIV infection. Treatment with HAART reduces the risk of epidemic Kaposi sarcoma, although it is possible for a person to develop epidemic Kaposi sarcoma while taking HAART.</Para><Para id="_239">For information about AIDS and its treatment,  see the <ExternalRef xref="https://hivinfo.nih.gov/home-page">HIVinfo website</ExternalRef>.</Para></SummarySection><SummarySection id="_154"><KeyPoint id="_155">Signs of epidemic Kaposi sarcoma can include  lesions that form in many parts of the body.</KeyPoint><Para id="_135">The <GlossaryTermRef href="CDR0000750109" dictionary="Cancer.gov" audience="Patient">signs</GlossaryTermRef> of epidemic Kaposi sarcoma can include <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef> in different parts of the body,  including any of the following: </Para><ItemizedList id="_172" Style="bullet"><ListItem>Skin.</ListItem><ListItem>Lining of the mouth.</ListItem><ListItem><GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">Lymph nodes</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046604" dictionary="Cancer.gov" audience="Patient">Stomach</GlossaryTermRef> and <GlossaryTermRef href="CDR0000046335" dictionary="Cancer.gov" audience="Patient">intestines</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">Lungs</GlossaryTermRef> and lining of the chest.</ListItem><ListItem><GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">Liver</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046593" dictionary="Cancer.gov" audience="Patient">Spleen</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_191">Kaposi sarcoma is sometimes found in the lining of the mouth during a regular dental check-up.</Para><Para id="_173"> In most patients with epidemic Kaposi sarcoma, the disease will spread to other parts of the body over time.</Para></SummarySection></SummarySection><SummarySection id="_50"><Title>Treatment Option Overview</Title><SummarySection id="_51"><SectMetaData><SectionType>Standard treatment</SectionType></SectMetaData><KeyPoint id="_52">There are different types of treatment for patients with Kaposi sarcoma.</KeyPoint><Para id="_53">Different types of treatments are available for patients with <GlossaryTermRef href="CDR0000045134" dictionary="Cancer.gov" audience="Patient">Kaposi sarcoma</GlossaryTermRef>. Some treatments are <GlossaryTermRef href="CDR0000044930" dictionary="Cancer.gov" audience="Patient">standard</GlossaryTermRef> (the currently used treatment), and some are being tested in <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trials</GlossaryTermRef>. A treatment clinical trial is a <GlossaryTermRef href="CDR0000651211" dictionary="Cancer.gov" audience="Patient">research study</GlossaryTermRef> meant to help improve current treatments or obtain information on new treatments for patients with <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef>. When clinical trials show that a new treatment is better than the      standard treatment, the new treatment may become the standard treatment.    Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.</Para></SummarySection><SummarySection id="_59"><SectMetaData><SectionType>Standard treatment</SectionType></SectMetaData><KeyPoint id="_60">The following  types of treatment are used to treat Kaposi sarcoma:</KeyPoint><Para id="_240">Treatment of epidemic Kaposi sarcoma combines treatment for Kaposi sarcoma with treatment for <GlossaryTermRef href="CDR0000044365" dictionary="Cancer.gov" audience="Patient">acquired immunodeficiency syndrome</GlossaryTermRef> (AIDS). The types of treatment used to treat Kaposi sarcoma include:</Para><SummarySection id="_241"><KeyPoint id="_242">HAART</KeyPoint><Para id="_243"><GlossaryTermRef href="CDR0000306504" dictionary="Cancer.gov" audience="Patient">Highly active antiretroviral therapy</GlossaryTermRef> (HAART) is a combination of several <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drugs</GlossaryTermRef> used to lessen the damage to the <GlossaryTermRef href="CDR0000046356" dictionary="Cancer.gov" audience="Patient">immune system</GlossaryTermRef> caused by <GlossaryTermRef href="CDR0000044366" dictionary="Cancer.gov" audience="Patient">human immunodeficiency virus</GlossaryTermRef> (HIV) infection. For many patients, HAART alone may be enough to treat epidemic Kaposi sarcoma. For other patients, HAART may be combined with other standard treatments to treat  epidemic Kaposi sarcoma.</Para><Para id="_244">For information about AIDS and its treatment,  see the <ExternalRef xref="https://hivinfo.nih.gov/home-page">HIVinfo website</ExternalRef>.</Para></SummarySection><SummarySection id="_65"><KeyPoint id="_66">Radiation therapy</KeyPoint><Para id="_67"><GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">Radiation therapy</GlossaryTermRef> is a cancer treatment that uses high-energy <GlossaryTermRef href="CDR0000045944" dictionary="Cancer.gov" audience="Patient">x-rays</GlossaryTermRef> or other types of <GlossaryTermRef href="CDR0000045072" dictionary="Cancer.gov" audience="Patient">radiation</GlossaryTermRef> to kill cancer <GlossaryTermRef href="CDR0000046476" dictionary="Cancer.gov" audience="Patient">cells</GlossaryTermRef> or keep them from growing. There are two types of radiation therapy:</Para><ItemizedList id="_231" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000046686" dictionary="Cancer.gov" audience="Patient">External radiation therapy</GlossaryTermRef> uses a machine outside the body to send radiation toward the area of the body with cancer.</ListItem><ListItem><GlossaryTermRef href="CDR0000046345" dictionary="Cancer.gov" audience="Patient">Internal radiation therapy</GlossaryTermRef> uses a <GlossaryTermRef href="CDR0000046550" dictionary="Cancer.gov" audience="Patient">radioactive</GlossaryTermRef> substance sealed in needles, <GlossaryTermRef href="CDR0000257219" dictionary="Cancer.gov" audience="Patient">seeds</GlossaryTermRef>, wires, or <GlossaryTermRef href="CDR0000045637" dictionary="Cancer.gov" audience="Patient">catheters</GlossaryTermRef> that are placed directly into or near the cancer.</ListItem></ItemizedList><Para id="_143">The way the radiation therapy is given depends on the type  of  the cancer being treated.  Certain types of external radiation therapy are used to treat  Kaposi sarcoma <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef>. <GlossaryTermRef href="CDR0000446193" dictionary="Cancer.gov" audience="Patient">Photon radiation therapy</GlossaryTermRef> treats lesions with high-energy light. <GlossaryTermRef href="CDR0000044667" dictionary="Cancer.gov" audience="Patient">Electron beam</GlossaryTermRef> radiation therapy uses tiny negatively charged particles called <GlossaryTermRef href="CDR0000702062" dictionary="Cancer.gov" audience="Patient">electrons</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_187"><KeyPoint id="_188">Surgery</KeyPoint><Para id="_189">The following <GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">surgical</GlossaryTermRef> procedures may be used for Kaposi sarcoma to treat small, surface lesions:</Para><ItemizedList id="_190" Style="bullet"><ListItem>Local <GlossaryTermRef href="CDR0000269459" dictionary="Cancer.gov" audience="Patient">excision</GlossaryTermRef>: The cancer is cut from the skin along with a small amount of normal <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissue</GlossaryTermRef> around it.</ListItem><ListItem><GlossaryTermRef href="CDR0000046434" dictionary="Cancer.gov" audience="Patient">Electrodesiccation</GlossaryTermRef> and <GlossaryTermRef href="CDR0000046459" dictionary="Cancer.gov" audience="Patient">curettage</GlossaryTermRef>: The <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumor</GlossaryTermRef> is cut from the skin with a <GlossaryTermRef href="CDR0000046460" dictionary="Cancer.gov" audience="Patient">curette</GlossaryTermRef> (a sharp, spoon-shaped tool). A needle-shaped <GlossaryTermRef href="CDR0000454755" dictionary="Cancer.gov" audience="Patient">electrode</GlossaryTermRef> is then used to treat the area with an electric current that stops the bleeding and destroys cancer cells that remain around the edge of the <GlossaryTermRef href="CDR0000441269" dictionary="Cancer.gov" audience="Patient">wound</GlossaryTermRef>. The process may be repeated one to three times during the surgery to remove all of the cancer.</ListItem></ItemizedList></SummarySection><SummarySection id="_245"><KeyPoint id="_246">Cryosurgery</KeyPoint><Para id="_247"><GlossaryTermRef href="CDR0000045407" dictionary="Cancer.gov" audience="Patient">Cryosurgery</GlossaryTermRef> is a treatment that uses an instrument to freeze and destroy <GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> tissue. This type of treatment is also called cryotherapy.</Para></SummarySection><SummarySection id="_68"><KeyPoint id="_69">Chemotherapy</KeyPoint><Para id="_70"><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.   When chemotherapy is taken by mouth or <GlossaryTermRef href="CDR0000044678" dictionary="Cancer.gov" audience="Patient">injected</GlossaryTermRef> into a <GlossaryTermRef href="CDR0000476471" dictionary="Cancer.gov" audience="Patient">vein</GlossaryTermRef> or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (<GlossaryTermRef href="CDR0000301626" dictionary="Cancer.gov" audience="Patient">systemic chemotherapy</GlossaryTermRef>). When chemotherapy is placed directly into the <GlossaryTermRef href="CDR0000046483" dictionary="Cancer.gov" audience="Patient">cerebrospinal fluid</GlossaryTermRef>, an <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organ</GlossaryTermRef>, tissue, or a body <GlossaryTermRef href="CDR0000463703" dictionary="Cancer.gov" audience="Patient">cavity</GlossaryTermRef> such as the <GlossaryTermRef href="CDR0000045070" dictionary="Cancer.gov" audience="Patient">abdomen</GlossaryTermRef>, the drugs mainly affect cancer cells in those areas (<GlossaryTermRef href="CDR0000046559" dictionary="Cancer.gov" audience="Patient">regional chemotherapy</GlossaryTermRef>). </Para><Para id="_248">In electrochemotherapy, <GlossaryTermRef href="CDR0000776353" dictionary="Cancer.gov" audience="Patient">intravenous chemotherapy</GlossaryTermRef> is given and a probe is used to send electric pulses to the tumor. The pulses make an opening in the <GlossaryTermRef href="CDR0000046294" dictionary="Cancer.gov" audience="Patient">membrane</GlossaryTermRef> around the tumor cell and allow the chemotherapy to get inside. </Para><Para id="_229">The way the chemotherapy is given depends on  where the Kaposi sarcoma lesions occur in the body. In Kaposi sarcoma, chemotherapy may be given in the following ways:         
</Para><ItemizedList id="_230" Style="bullet"><ListItem>For <GlossaryTermRef href="CDR0000046309" dictionary="Cancer.gov" audience="Patient">local</GlossaryTermRef> Kaposi sarcoma lesions, such as in the mouth, anticancer drugs may be injected directly into the lesion (<GlossaryTermRef href="CDR0000044684" dictionary="Cancer.gov" audience="Patient">intralesional</GlossaryTermRef> chemotherapy).</ListItem><ListItem>For local lesions on the skin, a <GlossaryTermRef href="CDR0000045927" dictionary="Cancer.gov" audience="Patient">topical</GlossaryTermRef> agent may be applied to the skin as a gel. Electrochemotherapy may also be used.</ListItem><ListItem>         For widespread lesions on the skin, intravenous chemotherapy may be given.</ListItem></ItemizedList><Para id="_170"><GlossaryTermRef href="CDR0000045753" dictionary="Cancer.gov" audience="Patient">Liposomal</GlossaryTermRef> chemotherapy    uses liposomes (very tiny fat particles) to carry anticancer drugs. <GlossaryTermRef href="CDR0000663502" dictionary="Cancer.gov" audience="Patient">Liposomal doxorubicin</GlossaryTermRef> is used to treat Kaposi sarcoma. The liposomes   build up  in Kaposi sarcoma tissue more than in healthy tissue, and the doxorubicin is released slowly. This increases the effect of the doxorubicin and causes less damage to healthy tissue.</Para><Para id="_206">See <ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/drugs/kaposi-sarcoma">Drugs Approved for Kaposi Sarcoma</ExternalRef> for more information.</Para></SummarySection><SummarySection id="_74"><KeyPoint id="_75">Immunotherapy</KeyPoint><Para id="_76"><GlossaryTermRef href="CDR0000045729" dictionary="Cancer.gov" audience="Patient">Immunotherapy</GlossaryTermRef> is a treatment that uses the patient's immune system to fight cancer.  Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer.  Immunotherapy with <GlossaryTermRef href="CDR0000045324" dictionary="Cancer.gov" audience="Patient">interferon alfa</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045426" dictionary="Cancer.gov" audience="Patient">interleukin-12</GlossaryTermRef> may be used to treat Kaposi sarcoma.</Para><Para id="_221">See <ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/drugs/kaposi-sarcoma">Drugs Approved for Kaposi Sarcoma</ExternalRef> for more information.</Para></SummarySection></SummarySection><SummarySection id="_83"><SectMetaData><SectionType>Treatment in clinical trials</SectionType></SectMetaData><KeyPoint id="_84">New types of treatment are being tested in clinical trials.</KeyPoint><Para id="_92"> This summary section describes treatments that are being 
         studied in 
    clinical trials.  
         It may not mention every new treatment being studied. Information about  clinical trials is available from the <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">NCI website</ExternalRef>.</Para><SummarySection id="_208"><KeyPoint id="_209">Targeted therapy</KeyPoint><Para id="_210"><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef> is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells.   <GlossaryTermRef href="CDR0000046066" dictionary="Cancer.gov" audience="Patient">Monoclonal antibody</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044833" dictionary="Cancer.gov" audience="Patient">tyrosine kinase inhibitors</GlossaryTermRef> (TKIs) are types of targeted therapy being studied in the treatment of Kaposi sarcoma.</Para><ItemizedList id="_254" Style="bullet"><ListItem><Para id="_211">Monoclonal antibodies are immune system <GlossaryTermRef href="CDR0000046092" dictionary="Cancer.gov" audience="Patient">proteins</GlossaryTermRef> made in the laboratory to treat many diseases, including cancer. As a cancer treatment, these <GlossaryTermRef href="CDR0000044918" dictionary="Cancer.gov" audience="Patient">antibodies</GlossaryTermRef> can attach to a specific target on cancer cells or other cells that may help cancer cells grow. The antibodies are able to then kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by <GlossaryTermRef href="CDR0000045738" dictionary="Cancer.gov" audience="Patient">infusion</GlossaryTermRef>. They may be used alone or to carry drugs, <GlossaryTermRef href="CDR0000046622" dictionary="Cancer.gov" audience="Patient">toxins</GlossaryTermRef>, or radioactive material directly to cancer cells. <GlossaryTermRef href="CDR0000046115" dictionary="Cancer.gov" audience="Patient">Bevacizumab</GlossaryTermRef> is a monoclonal antibody that may be used to treat Kaposi sarcoma.</Para><EmbeddedVideo id="_332" ref="CDR0000801837" hosting="youtube" unique_id="dxnjAc-rqz8" language="en" audience="Patients" template="Video75NoTitle"><VideoTitle>monoclonal antibodies: how monoclonal antibodies treat cancer</VideoTitle><Caption language="en">How do  monoclonal antibodies work to treat cancer? This video shows how monoclonal antibodies, such as trastuzumab, pembrolizumab, and rituximab, block molecules cancer cells need to grow, flag cancer cells for destruction by the body’s immune system, or deliver harmful substances to cancer cells. </Caption></EmbeddedVideo></ListItem><ListItem><Para id="_227">TKIs block signals needed for tumors to grow. <GlossaryTermRef href="CDR0000044893" dictionary="Cancer.gov" audience="Patient">Imatinib mesylate</GlossaryTermRef> is a TKI that may be used to treat Kaposi sarcoma.</Para></ListItem></ItemizedList></SummarySection></SummarySection><SummarySection id="_232"><KeyPoint id="_233">Treatment for Kaposi sarcoma may cause side effects.</KeyPoint><Para id="_232_md_73">For information about <GlossaryTermRef href="CDR0000046580" dictionary="Cancer.gov" audience="Patient">side effects</GlossaryTermRef> caused by treatment for cancer, visit our <ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/side-effects">Side Effects</ExternalRef> page.</Para></SummarySection><SummarySection id="_199"><KeyPoint id="_200">Patients may want to think about taking part in a clinical trial.</KeyPoint><Para id="_199_md_23">For some patients, taking part in a <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trial</GlossaryTermRef> may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer  treatments are safe and effective or better than the <GlossaryTermRef href="CDR0000044930" dictionary="Cancer.gov" audience="Patient">standard treatment</GlossaryTermRef>.</Para><Para id="_199_md_24">Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first  to receive a new treatment.</Para><Para id="_199_md_25">Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.</Para></SummarySection><SummarySection id="_201"><KeyPoint id="_202">Patients can enter clinical trials before, during, or after starting their cancer treatment.</KeyPoint><Para id="_201_md_29">Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the <GlossaryTermRef href="CDR0000046580" dictionary="Cancer.gov" audience="Patient">side effects</GlossaryTermRef> of cancer treatment.</Para><Para id="_201_md_30">Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trials search</ExternalRef> webpage. Clinical trials supported by other organizations can be found on the <ExternalRef xref="https://clinicaltrials.gov/">ClinicalTrials.gov</ExternalRef> website.</Para></SummarySection><SummarySection id="_203"><KeyPoint id="_204">Follow-up tests may be needed.</KeyPoint><Para id="_203_md_33">As you go through treatment, you  will have follow-up tests or check-ups. Some tests that were done to <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnose</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045885" dictionary="Cancer.gov" audience="Patient">stage</GlossaryTermRef> the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.</Para><Para id="_203_md_34">Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). </Para></SummarySection></SummarySection><SummarySection id="_94"><SectMetaData><SpecificDiagnosis ref="CDR0000039073">classic Kaposi sarcoma</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Treatment of Classic Kaposi Sarcoma</Title><Para id="_234">For information about the treatments listed below, see the <SummaryRef href="CDR0000442381#_59" url="/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><Para id="_95">Treatment  for single skin <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef> may include the following:</Para><ItemizedList id="_96" Style="bullet">
    <ListItem><GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">Radiation therapy</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">Surgery</GlossaryTermRef>.</ListItem>
    
   </ItemizedList><Para id="_140">Treatment  for skin lesions all over the body may include the following:</Para><ItemizedList id="_141" Style="bullet"><ListItem>Radiation therapy.</ListItem><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef>.</ListItem><ListItem>Electrochemotherapy.</ListItem></ItemizedList><Para id="_142">Treatment  for <GlossaryTermRef href="CDR0000045134" dictionary="Cancer.gov" audience="Patient">Kaposi sarcoma</GlossaryTermRef> that affects <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef> or the  <GlossaryTermRef href="CDR0000046189" dictionary="Cancer.gov" audience="Patient">gastrointestinal tract</GlossaryTermRef> usually includes chemotherapy with or without radiation therapy.</Para><Para id="_TrialSearch_94_19">Use our <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trial search</ExternalRef> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">General information</ExternalRef>  about clinical trials is also available.</Para></SummarySection><SummarySection id="_102"><SectMetaData><SpecificDiagnosis ref="CDR0000039075">AIDS-related Kaposi sarcoma</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Treatment of Epidemic Kaposi Sarcoma</Title><Para id="_333">For information about the treatments listed below, see the <SummaryRef href="CDR0000442381#_59" url="/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><Para id="_103">Treatment for epidemic <GlossaryTermRef href="CDR0000045134" dictionary="Cancer.gov" audience="Patient">Kaposi sarcoma</GlossaryTermRef> may include the following:</Para><ItemizedList id="_104" Style="bullet">
    <ListItem><GlossaryTermRef href="CDR0000306504" dictionary="Cancer.gov" audience="Patient">HAART</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">Surgery</GlossaryTermRef>, including local <GlossaryTermRef href="CDR0000269459" dictionary="Cancer.gov" audience="Patient">excision</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046434" dictionary="Cancer.gov" audience="Patient">electrodesiccation</GlossaryTermRef> and <GlossaryTermRef href="CDR0000046459" dictionary="Cancer.gov" audience="Patient">curettage</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045407" dictionary="Cancer.gov" audience="Patient">Cryosurgery</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">Radiation therapy</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> using one or more anticancer <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drugs</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045729" dictionary="Cancer.gov" audience="Patient">Immunotherapy</GlossaryTermRef> using <GlossaryTermRef href="CDR0000045324" dictionary="Cancer.gov" audience="Patient">interferon alfa</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045426" dictionary="Cancer.gov" audience="Patient">interleukin-12</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef> using <GlossaryTermRef href="CDR0000044893" dictionary="Cancer.gov" audience="Patient">imatinib</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046115" dictionary="Cancer.gov" audience="Patient">bevacizumab</GlossaryTermRef>.</ListItem>
   </ItemizedList><Para id="_TrialSearch_102_19">Use our <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trial search</ExternalRef> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">General information</ExternalRef>  about clinical trials is also available.</Para></SummarySection><SummarySection id="_192"><Title>To Learn More About Kaposi Sarcoma</Title><Para id="_193">For more information from the <GlossaryTermRef href="CDR0000044266" dictionary="Cancer.gov" audience="Patient">National Cancer Institute</GlossaryTermRef> about  Kaposi sarcoma, see the following:</Para><ItemizedList id="_207" Style="bullet"><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/surgery/cryosurgery">Cryosurgery to Treat Cancer</ExternalRef> </ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/drugs/kaposi-sarcoma">Drugs Approved for Kaposi Sarcoma</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy">Immunotherapy to Treat Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></ListItem></ItemizedList><Para id="_192_md_40">For general cancer information and other resources from the National Cancer Institute, visit:</Para><ItemizedList id="_192_md_41" Style="bullet"><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer">About Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/diagnosis-staging/staging">Cancer Staging</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/publications/patient-education/chemo-and-you">Chemotherapy and You: Support for People With Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/publications/patient-education/radiation-therapy-and-you">Radiation Therapy and You: Support for People With Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/coping">Coping with Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/coping/questions">Questions to Ask Your Doctor about Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://cancercontrol.cancer.gov/ocs/resources/survivors.html">For Survivors, Caregivers, and Advocates</ExternalRef></ListItem></ItemizedList></SummarySection><SummarySection id="_AboutThis_1"><Title>About This PDQ Summary</Title><SummarySection id="_AboutThis_2"><Title>About PDQ</Title><Para id="_AboutThis_3">Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in <ExternalRef xref="https://www.cancer.gov/espanol/publicaciones/pdq">Spanish</ExternalRef>.</Para><Para id="_AboutThis_4">PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government’s center of biomedical research.  The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.</Para></SummarySection><SummarySection id="_AboutThis_5"><Title>Purpose of This Summary</Title><Para id="_AboutThis_6">This PDQ cancer information summary has current information about the treatment of Kaposi sarcoma.  It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para></SummarySection><SummarySection id="_AboutThis_7"><Title>Reviewers and Updates</Title><Para id="_AboutThis_8">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Updated") is the date of the most recent change.
</Para><Para id="_AboutThis_9">The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the <ExternalRef xref="https://www.cancer.gov/publications/pdq/editorial-boards/adult-treatment">PDQ Adult Treatment Editorial Board</ExternalRef>.
</Para></SummarySection><SummarySection id="_AboutThis_10"><Title>Clinical Trial Information</Title><Para id="_AboutThis_11">A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
</Para><Para id="_AboutThis_12">Clinical trials can be found online at <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">NCI's website</ExternalRef>. For more information, call the <ExternalRef xref="https://www.cancer.gov/contact/contact-center">Cancer Information Service</ExternalRef> (CIS), NCI's contact center, at 1-800-4-CANCER (1-800-422-6237).
</Para></SummarySection><SummarySection id="_AboutThis_13"><Title>Permission to Use This Summary</Title><Para id="_AboutThis_14">PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as “NCI’s PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary].”
</Para><Para id="_AboutThis_15">The best way to cite this PDQ summary is:</Para><Para id="_AboutThis_21">PDQ® Adult Treatment Editorial Board. PDQ Kaposi Sarcoma Treatment. Bethesda, MD: National Cancer Institute. Updated  &lt;MM/DD/YYYY&gt;. Available at: <ExternalRef xref="https://www.cancer.gov/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq">https://www.cancer.gov/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq</ExternalRef>.  Accessed &lt;MM/DD/YYYY&gt;. [PMID: 26389178]</Para><Para id="_AboutThis_16">Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in <ExternalRef xref="https://visualsonline.cancer.gov/">Visuals Online</ExternalRef>. Visuals Online is a collection of more than 3,000 scientific images.
</Para></SummarySection><SummarySection id="_AboutThis_17"><Title>Disclaimer</Title><Para id="_AboutThis_18">The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the <ExternalRef xref="https://www.cancer.gov/about-cancer/managing-care">Managing Cancer Care</ExternalRef> page.</Para></SummarySection><SummarySection id="_AboutThis_19"><Title>Contact Us</Title><Para id="_AboutThis_20">More information about contacting us or receiving help with the Cancer.gov website can be found on our <ExternalRef xref="https://www.cancer.gov/contact">Contact Us for Help</ExternalRef> page. Questions can also be submitted to Cancer.gov through the website’s <ExternalRef xref="https://www.cancer.gov/contact/email-us">E-mail Us</ExternalRef>.</Para></SummarySection></SummarySection><PatientVersionOf ref="CDR0000062914"/><DateFirstPublished>2006-12-08</DateFirstPublished><DateLastModified>2023-05-17</DateLastModified></Summary>
